Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Surface reconstruction from routine CT-scan shows large anatomical variations of falx cerebri and tentorium cerebelli.

Staquet H, Francois PM, Sandoz B, Laporte S, Decq P, Goutagny S.

Acta Neurochir (Wien). 2020 Feb 7. doi: 10.1007/s00701-020-04256-2. [Epub ahead of print]

PMID:
32034496
2.

[What duration of anticoagulant treatment for PE/proximal DVT?]

Couturaud F, Girard P, Laporte S, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE.

Rev Mal Respir. 2019 Nov 8. pii: S0761-8425(19)30192-5. doi: 10.1016/j.rmr.2019.05.022. [Epub ahead of print] French. No abstract available.

PMID:
31711819
3.

[What are the options for the initial anticoagulant treatment of a PE and a proximal DVT?]

Couturaud F, Fischer AM, Laporte S, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE.

Rev Mal Respir. 2019 Nov 4. pii: S0761-8425(19)30169-X. doi: 10.1016/j.rmr.2019.05.003. [Epub ahead of print] French. No abstract available.

PMID:
31699457
4.

Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.

Gagnon L, Cao Y, Cho A, Sedki D, Huber T, Sakmar TP, Laporte SA.

J Biol Chem. 2019 Nov 15;294(46):17409-17420. doi: 10.1074/jbc.RA119.010324. Epub 2019 Sep 17.

PMID:
31530642
5.

Experimental analysis of the lower cervical spine in flexion with a focus on facet tracking.

Muth-Seng C, Brauge D, Soriau N, Sandoz B, Van den Abbeele M, Skalli W, Laporte S.

J Biomech. 2019 Aug 27;93:220-225. doi: 10.1016/j.jbiomech.2019.06.022. Epub 2019 Jul 1.

PMID:
31324381
6.

Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

Klok FA, Presles E, Tromeur C, Barco S, Konstantinides SV, Sanchez O, Pernod G, Raj L, Robin P, Le Roux PY, Hoffman C, Mélac S, Bertoletti L, Girard P, Laporte S, Mismetti P, Meyer G, Leroyer C, Couturaud F; PADIS‐PE Investigators.

Res Pract Thromb Haemost. 2019 May 25;3(3):364-371. doi: 10.1002/rth2.12214. eCollection 2019 Jul.

7.

[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version].

Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Jul 4. pii: S0761-8425(19)30210-4. doi: 10.1016/j.rmr.2019.05.038. [Epub ahead of print] French. No abstract available.

PMID:
31280989
8.

Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.

Raj L, Robin P, Le Mao R, Presles E, Tromeur C, Sanchez O, Pernod G, Bertoletti L, Jego P, Leven F, Lemarié CA, Martin A, Planquette B, Le Roux PY, Salaun PY, Nonent M, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Leroyer C, Couturaud F; PADIS-PE Investigators.

Thromb Haemost. 2019 Sep;119(9):1489-1497. doi: 10.1055/s-0039-1692424. Epub 2019 Jun 23.

PMID:
31230343
9.

High tolerance of progressive elastic compression in peripheral arterial disease.

Couzan S, Pouget JF, Le Hello C, Chapelle C, Laporte S, Mismetti P.

Vasa. 2019 Aug;48(5):413-417. doi: 10.1024/0301-1526/a000799. Epub 2019 Jun 4.

10.

Unraveling the molecular mechanisms of color expression in anthocyanins.

Rusishvili M, Grisanti L, Laporte S, Micciarelli M, Rosa M, Robbins RJ, Collins T, Magistrato A, Baroni S.

Phys Chem Chem Phys. 2019 Apr 24;21(17):8757-8766. doi: 10.1039/c9cp00747d.

PMID:
30968901
11.

Does obstructive sleep apnea affect exercise capacity and the hemodynamic response to exercise? An individual patient data and aggregate meta-analysis.

Berger M, Kline CE, Cepeda FX, Rizzi CF, Chapelle C, Laporte S, Hupin D, Raffin J, Costes F, Hargens TA, Barthélémy JC, Roche F.

Sleep Med Rev. 2019 Jun;45:42-53. doi: 10.1016/j.smrv.2019.03.002. Epub 2019 Mar 14. Review.

PMID:
30933881
12.

Methods to Monitor the Trafficking of β-Arrestin/G Protein-Coupled Receptor Complexes Using Enhanced Bystander BRET.

Cao Y, Namkung Y, Laporte SA.

Methods Mol Biol. 2019;1957:59-68. doi: 10.1007/978-1-4939-9158-7_3.

PMID:
30919346
13.

β-Arrestins: Multitask Scaffolds Orchestrating the Where and When in Cell Signalling.

Laporte SA, Scott MGH.

Methods Mol Biol. 2019;1957:9-55. doi: 10.1007/978-1-4939-9158-7_2. Review.

PMID:
30919345
14.

Corrigendum: An Initial Passive Phase That Limits the Time to Recover and Emphasizes the Role of Proprioceptive Information.

Le Goic M, Wang D, Vidal C, Chiarovano E, Lecompte J, Laporte S, Duysens J, Vidal PP.

Front Neurol. 2019 Feb 27;10:118. doi: 10.3389/fneur.2019.00118. eCollection 2019.

15.

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].

Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. French. No abstract available.

PMID:
30799126
16.

Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach.

Claisse G, Zufferey PJ, Trone JC, Maillard N, Delavenne X, Laporte S, Ollier E.

Br J Clin Pharmacol. 2019 Jun;85(6):1215-1226. doi: 10.1111/bcp.13904. Epub 2019 Apr 7. Review.

PMID:
30768726
17.

Collaborative sensorimotor intelligence: the scrum as a model.

Wang D, Mahe G, Fang J, Piscione J, Couvet S, Retiere D, Laporte S, Vidal PP.

BMJ Open Sport Exerc Med. 2018 Dec 27;4(1):e000407. doi: 10.1136/bmjsem-2018-000407. eCollection 2018.

18.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

19.

An Initial Passive Phase That Limits the Time to Recover and Emphasizes the Role of Proprioceptive Information.

Le Goic M, Wang D, Vidal C, Chiarovano E, Lecompte J, Laporte S, Duysens J, Vidal PP.

Front Neurol. 2018 Nov 22;9:986. doi: 10.3389/fneur.2018.00986. eCollection 2018. Erratum in: Front Neurol. 2019 Feb 27;10:118.

20.

FZD5 is a Gαq-coupled receptor that exhibits the functional hallmarks of prototypical GPCRs.

Wright SC, Cañizal MCA, Benkel T, Simon K, Le Gouill C, Matricon P, Namkung Y, Lukasheva V, König GM, Laporte SA, Carlsson J, Kostenis E, Bouvier M, Schulte G, Hoffmann C.

Sci Signal. 2018 Dec 4;11(559). pii: eaar5536. doi: 10.1126/scisignal.aar5536.

PMID:
30514810
21.

Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.

Namkung Y, LeGouill C, Kumar S, Cao Y, Teixeira LB, Lukasheva V, Giubilaro J, Simões SC, Longpré JM, Devost D, Hébert TE, Piñeyro G, Leduc R, Costa-Neto CM, Bouvier M, Laporte SA.

Sci Signal. 2018 Dec 4;11(559). pii: eaat1631. doi: 10.1126/scisignal.aat1631.

PMID:
30514808
22.

Novel Pathogenesis of Hypertension and Diastolic Dysfunction Caused by M3R (Muscarinic Cholinergic 3 Receptor) Signaling.

Deng AY, deBlois D, Laporte SA, Gelinas D, Tardif JC, Thorin E, Shi Y, Raignault A, Ménard A.

Hypertension. 2018 Sep;72(3):755-764. doi: 10.1161/HYPERTENSIONAHA.118.11385.

PMID:
30354759
23.

Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9.

Luttrell LM, Wang J, Plouffe B, Smith JS, Yamani L, Kaur S, Jean-Charles PY, Gauthier C, Lee MH, Pani B, Kim J, Ahn S, Rajagopal S, Reiter E, Bouvier M, Shenoy SK, Laporte SA, Rockman HA, Lefkowitz RJ.

Sci Signal. 2018 Sep 25;11(549). pii: eaat7650. doi: 10.1126/scisignal.aat7650.

24.

Role of platelet α2-adrenoreceptor in biological low response to Clopidogrel for patients with non cardioembolic ischemic stroke or transient ischemic attack.

Varvat J, Epinat M, Montmartin A, Accassat S, Boutet C, Garcin A, Li G, Malergue F, Chapelle C, Laporte S, Garnier P, Lambert C, Mallouk N, Mismetti P.

Am J Transl Res. 2018 Aug 15;10(8):2712-2721. eCollection 2018.

25.

Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation Study.

Chauleur C, Gris JC, Laporte S, Chapelle C, Bertoletti L, Equy V, Gaucherand P, Bazan E, Dupuis O, Gallot D, Mismetti P; STRATHEGE Investigators and The STRATHEGE Group.

Thromb Haemost. 2018 Sep;118(9):1564-1571. doi: 10.1055/s-0038-1668524. Epub 2018 Aug 13.

PMID:
30103244
26.

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).

Decousus H, Bourmaud A, Fournel P, Bertoletti L, Labruyère C, Presles E, Merah A, Laporte S, Stefani L, Piano FD, Jacquin JP, Meyer G, Chauvin F; ONCOCIP Investigators.

Blood. 2018 Aug 16;132(7):707-716. doi: 10.1182/blood-2018-03-837153. Epub 2018 Jul 6.

PMID:
29980524
27.

Inconsistent anticipatory postural adjustments (APAs) in rugby players: a source of injuries?

Wang D, Mahe G, Fang J, Piscione J, Couvet S, Retiere D, Laporte S, Vidal PP.

BMJ Open Sport Exerc Med. 2018 Jun 4;4(1):e000303. doi: 10.1136/bmjsem-2017-000303. eCollection 2018.

28.

Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time-to-event analysis.

Zufferey PJ, Ollier E, Delavenne X, Laporte S, Mismetti P, Duffull SB.

Br J Clin Pharmacol. 2018 Oct;84(10):2242-2251. doi: 10.1111/bcp.13663. Epub 2018 Jul 14.

29.

Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor.

Chun LS, Vekariya RH, Free RB, Li Y, Lin DT, Su P, Liu F, Namkung Y, Laporte SA, Moritz AE, Aubé J, Frankowski KJ, Sibley DR.

Front Synaptic Neurosci. 2018 Feb 21;10:2. doi: 10.3389/fnsyn.2018.00002. eCollection 2018.

30.

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis.

Trone JC, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, Magné N, Laporte S.

Ann Oncol. 2018 Apr 1;29(4):803-811. doi: 10.1093/annonc/mdy035.

31.

Utilisation des objets connectés en recherche clinique.

Dhainaut JF, Huot L, Bouchara Pomar V, Dubray C; les participants à la table ronde « Technologies de santé » des Ateliers de Giens XXXIII, Augé P, Barthélémy P, Belghiti J, Bureau S, Cassagnes J, Deblois S, Di Palma M, Dorsay G, Duchossoy L, Durand-Salmon F, Escudier T, Fiorini M, Franc S, Gelpi O, Laporte S, Lavallée E, Lethiec F, Meunier JP, Peyret O, Samalin L, Vicaut E; et contributeurs.

Therapie. 2018 Feb;73(1):41-51. doi: 10.1016/j.therap.2017.11.002. Epub 2017 Dec 11. French. No abstract available.

PMID:
29395302
32.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

33.

A subject-specific biomechanical control model for the prediction of cervical spine muscle forces.

Van den Abbeele M, Li F, Pomero V, Bonneau D, Sandoz B, Laporte S, Skalli W.

Clin Biomech (Bristol, Avon). 2018 Jan;51:58-66. doi: 10.1016/j.clinbiomech.2017.12.001. Epub 2017 Dec 6.

PMID:
29227919
34.

Intra cranial volume quantification from 3D reconstruction based on CT-scan data.

François PM, Sandoz B, Laporte S, Decq P.

Comput Methods Biomech Biomed Engin. 2017 Oct;20(sup1):81-82. doi: 10.1080/10255842.2017.1382870. No abstract available.

PMID:
29088687
35.

Quantification of the stress generated by the endoscopic movement in the brain parenchyma during intra ventricular surgical procedure.

François PM, Sandoz B, Decq P, Laporte S.

Comput Methods Biomech Biomed Engin. 2017 Oct;20(sup1):79-80. doi: 10.1080/10255842.2017.1382871. No abstract available.

PMID:
29088686
36.

Modelling of fascia lata rupture during tensile tests via the discrete element method.

Muth-Seng C, Gras LL, Roux A, Laporte S.

Comput Methods Biomech Biomed Engin. 2017 Oct;20(sup1):147-148. doi: 10.1080/10255842.2017.1382904. No abstract available.

PMID:
29088662
37.

Evaluation of a Passive Model to Mimic Dynamic Head/Neck Movements.

Saraç H, Laporte S, Sandoz B.

Comput Methods Biomech Biomed Engin. 2017 Oct;20(sup1):191-192. doi: 10.1080/10255842.2017.1382927. No abstract available.

PMID:
29088596
38.

Will Automated Driving Technologies Make Today's Effective Restraint Systems Obsolete?

Subit D, Vézin P, Laporte S, Sandoz B.

Am J Public Health. 2017 Oct;107(10):1590-1592. doi: 10.2105/AJPH.2017.304009. No abstract available.

39.

Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.

Raia-Barjat T, Prieux C, Gris JC, Chapelle C, Laporte S, Chauleur C.

J Matern Fetal Neonatal Med. 2019 Jan;32(2):248-257. doi: 10.1080/14767058.2017.1378325. Epub 2017 Sep 22.

PMID:
28889770
40.

Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study.

Di Bartolomeo A, Chauleur C, Tardy B, Piot M, Gris JC, Chapelle C, Noblot E, Laporte S, Raia-Barjat T.

PLoS One. 2017 Jul 12;12(7):e0181474. doi: 10.1371/journal.pone.0181474. eCollection 2017.

41.

Evaluation of direct oral anticoagulants in superficial-vein thrombosis.

Frappé P, Bertoletti L, Le Hello C, Décousus H, Laporte S.

Lancet Haematol. 2017 Jun;4(6):e254. doi: 10.1016/S2352-3026(17)30062-5. No abstract available.

PMID:
28583285
42.

[False positive results or what's the probability that a significant P-value indicates a true effect?]

Cucherat M, Laporte S.

Therapie. 2017 Sep;72(4):421-426. doi: 10.1016/j.therap.2016.09.021. Epub 2017 May 8. French.

PMID:
28577824
43.

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.

Laporte S, Chapelle C, Bertoletti L, Ollier E, Zufferey P, Lega JC, Merah A, Décousus H, Schulman S, Meyer G, Cucherat M, Mismetti P.

J Thromb Haemost. 2017 Aug;15(8):1547-1558. doi: 10.1111/jth.13740. Epub 2017 Jul 5. Review.

44.

A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling.

Beautrait A, Paradis JS, Zimmerman B, Giubilaro J, Nikolajev L, Armando S, Kobayashi H, Yamani L, Namkung Y, Heydenreich FM, Khoury E, Audet M, Roux PP, Veprintsev DB, Laporte SA, Bouvier M.

Nat Commun. 2017 Apr 18;8:15054. doi: 10.1038/ncomms15054.

45.

[Editorial].

Laporte S, Chauvin F, Bourmaud A, Presles E.

Rev Epidemiol Sante Publique. 2017 May;65 Suppl 2:S45-S46. doi: 10.1016/j.respe.2017.03.002. Epub 2017 Mar 31. French. No abstract available.

PMID:
28372835
46.

Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study.

Di Bartolomeo A, Chauleur C, Gris JC, Chapelle C, Noblot E, Laporte S, Raia-Barjat T.

PLoS One. 2017 Mar 22;12(3):e0173596. doi: 10.1371/journal.pone.0173596. eCollection 2017. Erratum in: PLoS One. 2017 Jul 12;12 (7):e0181474.

47.

Introductory letter to the special issue "Country in focus, pharmacology in France".

Perault-Pochat MC, Laporte S.

Pharmacol Res. 2017 Apr;118:1. doi: 10.1016/j.phrs.2017.01.021. No abstract available.

PMID:
28283093
48.

Lived experience of having a child with stroke: A qualitative study.

Soufi S, Chabrier S, Bertoletti L, Laporte S, Darteyre S.

Eur J Paediatr Neurol. 2017 May;21(3):542-548. doi: 10.1016/j.ejpn.2017.01.007. Epub 2017 Jan 25.

PMID:
28185801
49.

Secondary Prevention of Childhood Arterial Ischemic Stroke.

Darteyre S, Renaud C, Fluss J, Laporte S, Bertoletti L, Chabrier S.

J Child Neurol. 2017 Apr;32(5):488-493. doi: 10.1177/0883073816686911. Epub 2017 Jan 27.

PMID:
28128037
50.

Shear waves elastography for assessment of human Achilles tendon's biomechanical properties: an experimental study.

Haen TX, Roux A, Soubeyrand M, Laporte S.

J Mech Behav Biomed Mater. 2017 May;69:178-184. doi: 10.1016/j.jmbbm.2017.01.007. Epub 2017 Jan 6.

PMID:
28086149

Supplemental Content

Loading ...
Support Center